60 01/10/2023 30/09/2024 2024-09-30 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-10-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 02164334 2023-10-01 2024-09-30 02164334 2024-09-30 02164334 2023-09-30 02164334 2022-10-01 2023-09-30 02164334 2023-09-30 02164334 2022-09-30 02164334 core:PlantMachinery 2023-10-01 2024-09-30 02164334 core:FurnitureFittingsToolsEquipment 2023-10-01 2024-09-30 02164334 bus:Director1 2023-10-01 2024-09-30 02164334 bus:Director2 2023-10-01 2024-09-30 02164334 bus:Director3 2023-10-01 2024-09-30 02164334 core:NetGoodwill 2024-09-30 02164334 core:LandBuildings core:OwnedOrFreeholdAssets 2023-09-30 02164334 core:PlantMachinery 2023-09-30 02164334 core:FurnitureFittingsToolsEquipment 2023-09-30 02164334 core:LandBuildings core:OwnedOrFreeholdAssets 2024-09-30 02164334 core:PlantMachinery 2024-09-30 02164334 core:FurnitureFittingsToolsEquipment 2024-09-30 02164334 core:WithinOneYear 2024-09-30 02164334 core:WithinOneYear 2023-09-30 02164334 core:ShareCapital 2024-09-30 02164334 core:ShareCapital 2023-09-30 02164334 core:RevaluationReserve 2024-09-30 02164334 core:RevaluationReserve 2023-09-30 02164334 core:RetainedEarningsAccumulatedLosses 2024-09-30 02164334 core:RetainedEarningsAccumulatedLosses 2023-09-30 02164334 core:NetGoodwill 2023-09-30 02164334 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 02164334 core:Non-currentFinancialInstruments 2024-09-30 02164334 core:Non-currentFinancialInstruments 2023-09-30 02164334 core:LandBuildings core:OwnedOrFreeholdAssets 2023-09-30 02164334 core:PlantMachinery 2023-09-30 02164334 core:FurnitureFittingsToolsEquipment 2023-09-30 02164334 bus:Director1 2023-09-30 02164334 bus:Director3 2023-09-30 02164334 bus:Director3 2024-09-30 02164334 bus:Director1 2023-09-30 02164334 bus:Director2 2022-09-30 02164334 bus:Director3 2022-09-30 02164334 bus:Director3 2023-09-30 02164334 bus:Director1 2022-10-01 2023-09-30 02164334 bus:Director2 2022-10-01 2023-09-30 02164334 bus:Director3 2022-10-01 2023-09-30 02164334 bus:SmallEntities 2023-10-01 2024-09-30 02164334 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 02164334 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 02164334 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 02164334 bus:FullAccounts 2023-10-01 2024-09-30
Company registration number: 02164334
St Johns Nursing Home Limited
Unaudited filleted financial statements
30 September 2024
St Johns Nursing Home Limited
Contents
Statement of financial position
Notes to the financial statements
St Johns Nursing Home Limited
Statement of financial position
30 September 2024
2024 2023
Note £ £ £ £
Fixed assets
Intangible assets 7 - -
Tangible assets 8 2,581,853 2,566,915
Investments 9 1 1
_______ _______
2,581,854 2,566,916
Current assets
Debtors 10 94,181 775,983
Cash at bank and in hand 1,603,155 676,448
_______ _______
1,697,336 1,452,431
Creditors: amounts falling due
within one year 11 ( 834,120) ( 703,610)
_______ _______
Net current assets 863,216 748,821
_______ _______
Total assets less current liabilities 3,445,070 3,315,737
_______ _______
Net assets 3,445,070 3,315,737
_______ _______
Capital and reserves
Called up share capital 130 130
Revaluation reserve 406,559 406,559
Profit and loss account 3,038,381 2,909,048
_______ _______
Shareholders funds 3,445,070 3,315,737
_______ _______
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 09 June 2025 , and are signed on behalf of the board by:
N Baloo
Director
Company registration number: 02164334
St Johns Nursing Home Limited
Notes to the financial statements
Year ended 30 September 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 129 Haling Park Road, South Croydon, Surrey, CR2 6NN.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery - 25 % reducing balance
Fittings fixtures and equipment - 25 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
4. Operating profit
Operating profit is stated after charging/(crediting):
2024 2023
£ £
Depreciation of tangible assets 73,298 68,321
_______ _______
5. Staff costs
The aggregate payroll costs incurred during the year were:
2024 2023
£ £
Wages and salaries 1,781,090 1,712,440
Other pension costs 55,243 43,187
_______ _______
1,836,333 1,755,627
_______ _______
6. Employee numbers
The average number of persons employed by the company during the year amounted to 60 (2023: 58 ).
7. Intangible assets
Goodwill Total
£ £
Cost
At 1 October 2023 and 30 September 2024 25,000 25,000
_______ _______
Amortisation
At 1 October 2023 and 30 September 2024 25,000 25,000
_______ _______
Carrying amount
At 30 September 2024 - -
_______ _______
At 30 September 2023 - -
_______ _______
8. Tangible assets
Freehold property Plant and machinery Fixtures, fittings and equipment Total
£ £ £ £
Cost
At 1 October 2023 2,361,958 1,513,264 207,166 4,082,388
Additions - - 88,236 88,236
_______ _______ _______ _______
At 30 September 2024 2,361,958 1,513,264 295,402 4,170,624
_______ _______ _______ _______
Depreciation
At 1 October 2023 - 1,391,590 123,883 1,515,473
Charge for the year - 30,418 42,880 73,298
_______ _______ _______ _______
At 30 September 2024 - 1,422,008 166,763 1,588,771
_______ _______ _______ _______
Carrying amount
At 30 September 2024 2,361,958 91,256 128,639 2,581,853
_______ _______ _______ _______
At 30 September 2023 2,361,958 121,674 83,283 2,566,915
_______ _______ _______ _______
9. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1 October 2023 and 30 September 2024 1 1
_______ _______
Impairment
At 1 October 2023 and 30 September 2024 - -
_______ _______
Carrying amount
At 30 September 2024 1 1
_______ _______
At 30 September 2023 1 1
_______ _______
10. Debtors
2024 2023
£ £
Trade debtors 63,799 106,853
Amounts owed by group undertakings and undertakings in which the company has a participating interest - 635,517
Other debtors 30,382 33,613
_______ _______
94,181 775,983
_______ _______
11. Creditors: amounts falling due within one year
2024 2023
£ £
Trade creditors 64,295 114,411
Amounts owed to group undertakings and undertakings in which the company has a participating interest 674,657 368,794
Corporation tax 58,297 62,597
Other creditors 36,871 157,808
_______ _______
834,120 703,610
_______ _______
12. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
N Baloo ( 5,000) 5,000 -
R Baloo - - -
S Aguilar ( 87,700) 74,796 ( 12,904)
_______ _______ _______
( 92,700) 79,796 ( 12,904)
_______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
N Baloo - ( 5,000) ( 5,000)
R Baloo ( 250,000) 250,000 -
S Aguilar ( 250,000) 162,300 ( 87,700)
_______ _______ _______
( 500,000) 407,300 ( 92,700)
_______ _______ _______